TOFIDENCE
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $5.6M | 24 | 14 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $5.6M | 4 | 99.8% |
| Consulting Fee | $6,538 | 7 | 0.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,635 | 1 | 0.0% |
| Food and Beverage | $256.35 | 9 | 0.0% |
| Education | $187.50 | 3 | 0.0% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A Randomized, Double-Blind, Parallel-Group, Phase I Study to Evaluate the Pharmacokinetics, Safety, and Immunogenicity of BIIB800 s.c. compared to the Reference Product Actemra® in Healthy Subjects | Biogen, Inc. | $5.6M | 0 |
Top Doctors Receiving Payments for TOFIDENCE
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Madison, WI | $5.6M | 4 |
| , M.D | Rheumatology | New York, NY | $3,742 | 4 |
| , MD | Rheumatology | Phoenix, AZ | $2,044 | 2 |
| , M.D | Rheumatology | New York, NY | $1,496 | 2 |
| , MD | Rheumatology | Destin, FL | $954.00 | 1 |
| , M.D | Rheumatology | Dallas, TX | $109.96 | 1 |
| , M.D | Specialist | San Diego, CA | $62.50 | 1 |
| , D.O | Rheumatology | Glendale, AZ | $62.50 | 1 |
| , M.D | Internal Medicine | Beverly Hills, CA | $44.12 | 2 |
| , AGNP | Gerontology | Casa Grande, AZ | $21.53 | 1 |
| , M.D | Obesity Medicine | Carlsbad, CA | $17.92 | 1 |
| , APRN | Nurse Practitioner | Surprise, AZ | $16.15 | 1 |
| Madison Abrams | Physician Assistant | Surprise, AZ | $16.15 | 1 |
| , MD | Rheumatology | Mckinney, TX | $15.26 | 1 |
| , M.D | Rheumatology | Mckinney, TX | $15.26 | 1 |
Manufacturing Companies
- Biogen, Inc. $5.6M
Product Information
- Type Biological
- Total Payments $5.6M
- Total Doctors 14
- Transactions 24
About TOFIDENCE
TOFIDENCE is a biological associated with $5.6M in payments to 14 healthcare providers, recorded across 24 transactions in the CMS Open Payments database. The primary manufacturer is Biogen, Inc..
Payment data is available from 2024 to 2024. In 2024, $5.6M was paid across 24 transactions to 14 doctors.
The most common payment nature for TOFIDENCE is "Unspecified" ($5.6M, 99.8% of total).
TOFIDENCE is associated with 1 research study, including "A Randomized, Double-Blind, Parallel-Group, Phase I Study to Evaluate the Pharmacokinetics, Safety, and Immunogenicity of BIIB800 s.c. compared to the Reference Product Actemra® in Healthy Subjects" ($5.6M).